Skip to main content
Monica (Museteanu) Mita, MD, Oncology, San Antonio, TX

MonicaMirela(Museteanu)MitaMD

Oncology San Antonio, TX

Breast Cancer, Sarcoma

Co-Director of Early Phase Development Therapy and Co-Director of Breast Medical Oncology, Hoag

Dr. Mita is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mita's full profile

Already have an account?

  • Office

    7979 Wurzbach Rd
    San Antonio, TX 78229
    Phone+1 210-450-1000
    Fax+1 210-450-1150

Summary

  • Monica Mita, M.Sc., M.H.D.S., is a medical oncologist at Hoag Family Cancer Institute specializing in breast cancer and development of new therapies for cancer. An accomplished researcher, Dr. Mita has focused on phase I clinical trials in oncology, novel drugs and targeted therapies. She has served as the principal investigator and co-principal investigator on over 100 research studies. After earning her Medical Degree at the Carol Davila University of Medicine and Pharmacy in Bucharest, Romania, she completed her specialty training in cancer research at Paul Brousse Hospital in Villejuif, France and the Rene Huguenin Center in Saint-Cloud, France, including obtaining a Masters Degree in Science. She received additional specialty training in oncology at the Claudius Regaud Center, Purpan Hospital, the Saint-Antoine Hospital and Childrens Hospital, in France. Dr. Mita completed an Advanced Oncology Drug Development fellowship and an Oncology fellowship at the University of Texas, Health Science Center in San Antonio, Texas. She also completed an executive master’s degree in Health Delivery Science from Cedars-Sinai Medical Center. Dr. Mita has authored and co-authored more than 200 clinical abstracts, primarily focusing on the effects of various drugs on breast cancer treatment. She has given numerous lectures and presented more than 100 abstracts internationally. Dr. Mita is a member of the American Society for Clinical Oncology, the American Association for Cancer Research and the Southwest Oncology Group, Breast and Early Therapeutics.

Education & Training

  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2002 - 2005
  • Carol Davila University of Medicine and Pharmacy
    Carol Davila University of Medicine and PharmacyClass of 1992

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 2005 - 2025
  • CA State Medical License
    CA State Medical License 2011 - 2025
  • TX State Medical License
    TX State Medical License 2006 - 2025

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Pharmacodynamic and clinical activity of RGX-104, a first-in-class immunotherapy targeting the liver-X nuclear hormone receptor (LXR), in patients with refractory mali... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
  • New Therapeutics in Oncology: The Road to Personalized Medicine 
    Cedars Sinai Medical Center, Los Angeles, California - 10/26/2012

Press Mentions

  • Hoag Taps 2 Oncology Leaders from Cedars-Sinai
    Hoag Taps 2 Oncology Leaders from Cedars-SinaiApril 26th, 2024
  • One Man’s Search for the DNA Data That Could Save His Life
    One Man’s Search for the DNA Data That Could Save His LifeNovember 19th, 2020
  • Forever Young? There’s Officially an Anti-Aging Pill for Dogs
    Forever Young? There’s Officially an Anti-Aging Pill for DogsOctober 8th, 2016
  • Join now to see all

Professional Memberships

Other Languages

  • French